Posted by Michael Wonder on 19 May 2020
Gilead ups its donation of the COVID-19 drug remdesivir for U.S. hospitals
18 May 2020 - Gilead Sciences, the drug company behind the experimental COVID-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000.
The new number appeared, with no acknowledgement of the shift, in a letter that a U.S. Department of Health and Human Services official sent to governors on Saturday.
